Latest Breaking News On - Charlotte jones burton - Page 3 : comparemela.com

(Photo credit: Getty Images/Westend61) Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients. During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsuka s Global Clinical Development on Nephrology, Dr. Charlotte Jones-Burton, to talk about innovating for rare disease, digital in clinical trials and lessons learned from past tech partnerships. One of Otsuka s treatment areas focuses on autosomal dominant polycystic kidney disease (ADPKD), a genetic disease that requires substantial monitoring. There have always been challenges for patients living with this disease, which have been exacerbated during the pandemic.

Abilify myciteCharlotte jones burtonOtsuka global clinical development on nephrologyGlobal clinical developmentMonitoring toolClick therapeuticsProject baselineசார்லோட் ஜோன்ஸ் பர்டன்ஓத்சுக் உலகளாவிய மருத்துவ வளர்ச்சி ஆன் நெப்ராலஜிஉலகளாவிய மருத்துவ வளர்ச்சிகண்காணிப்பு கருவிகிளிக் செய்க சிகிச்சைப்ராஜெக்ட் அடிப்படை